A Study to Evaluate the Lipid Regulating Effects of TRIA-662
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness and safety of TRIA-662 (also
known as 1-MNA) in treating elevated triglyceride levels in patients not receiving lipid
lowering treatment. This study will determine the effects of TRIA-662 on commonly measured
blood fats that are known to be important in the prevention of vascular disease.